An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
Clinical trial NCT06625398 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06625398
- Sponsor
- Viridian Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2026-03-04
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.